Today: 20 April 2026
Gold Price Today Slips as Dollar, Oil Shock Put $5,000 Forecast in Doubt
20 April 2026
2 mins read

Gold Price Today Slips as Dollar, Oil Shock Put $5,000 Forecast in Doubt

NEW YORK, April 20, 2026, 10:43 EDT

  • Gold slipped to its lowest in a week, pressured by gains in the dollar and higher U.S. yields.
  • Gold lost some safe-haven appeal as oil surged on new U.S.-Iran tensions.
  • Analysts flagged $5,000 as the immediate hurdle bulls have to clear.

Gold slipped Monday, with spot prices hitting a one-week low as strength in the dollar and a bump in oil prices took the shine off bullion. By 9:23 a.m. EDT, spot gold had dropped 0.3% to $4,818.03 an ounce. June U.S. gold futures lost 0.8%, settling at $4,839.10.

Gold usually finds buyers during geopolitical flare-ups, but inflation is tugging prices lower this time. U.S.-Iran tensions have lifted oil roughly 5%, stoking worries that higher energy prices may keep inflation stubborn and rates elevated.

Gold tends to struggle when rates climb, since it doesn’t offer interest. Rising Treasury yields tilt the scales toward bonds, while a firmer dollar pushes up the price of bullion for buyers outside the U.S.

Reuters reported that pressure ratcheted up after the U.S. seized an Iranian cargo ship and Tehran threatened to hit back, shaking confidence in a ceasefire. As a result, most movement through the Strait of Hormuz stayed frozen.

Fawad Razaqzada, a market analyst with City Index and FOREX.com, flagged the Middle East situation as a reason he’s turned “slightly to the downside” on gold. He pointed to the chance of another oil spike, warning it could push the dollar and bond yields higher. Reuters

Eyes now shift to the $5,000 mark in the near-term outlook. Jim Wyckoff, senior analyst at Kitco Metals, noted June gold bulls are looking for a close above that threshold. On the flip side, traders have cited “bearish daily elements”—the dollar and yields among them. Reuters

Han Tan, chief market analyst at Bybit, pointed out that oil’s jump has pushed “inflation risks” front and center, with gold now “taking a backseat” as traders favor the dollar for safety. According to Tan, spot gold looks set to trade below $5,000, barring any significant and lasting de-escalation. kitco.com

Yet the outlook for gold remains mixed. “Structural demand drivers persist,” said Nikos Tzabouras, senior market analyst at Jefferies-owned Tradu.com, highlighting ongoing central-bank purchases, concerns about de-dollarisation, and worries over currency debasement as key factors keeping bullion supported. kitco.com

Traders kept up the momentum. At 10:00 a.m. in New York, AP reported open interest in COMEX gold futures reaching 360,881 contracts, a jump of 14,538 from the last tally. Estimated volume came in at 89,375 contracts. COMEX handles most U.S. gold futures, with each contract representing 100 troy ounces.

Silver tracked gold lower, dropping 0.8% to $80.18 per ounce. Platinum retreated 1.2% to $2,077.35, while palladium edged down 0.3% to $1,554.48—both platinum and palladium briefly hit their lowest in a week.

Neither bulls nor bears have an easy setup here. A sharper oil shock might hold up the dollar and yields, keeping gold stuck under $5,000, even with higher geopolitical risk. On the flip side, if U.S.-Iran tensions cool off or U.S. yields slip, that could clear the way for buyers to push gold back toward that $5,000 mark.

At this point, gold is behaving more like an inflation play than a pure safe haven. The short-term outlook hinges less on nerves, more on whether oil, the dollar, and Treasury yields keep pushing the same way.

Stock Market Today

  • Top Aerospace Stocks Like RTX and Leidos Show Earnings Surprise Potential
    April 20, 2026, 11:06 AM EDT. Earnings per share (EPS) surprises can move stock prices sharply, especially near earnings dates. Zacks' Earnings ESP-a metric comparing the most current analyst estimates to consensus forecasts-helps identify likely earnings beaters. Aerospace giant RTX, with a Zacks Rank of #3 (Hold), has an ESP of +1.38% ahead of its January 28 report, signaling a positive surprise potential. Similarly, defense contractor Leidos (LDOS), ranked #2 (Buy), boasts strong earnings estimates and an ESP over +1% before its February 11 earnings. Historically, combining positive ESP with favorable Zacks Ranks yields significant returns. Investors looking to boost portfolios might consider these aerospace names ahead of earnings announcements.

Latest article

Gold Price Today Slips as Dollar, Oil Shock Put $5,000 Forecast in Doubt

Gold Price Today Slips as Dollar, Oil Shock Put $5,000 Forecast in Doubt

20 April 2026
Gold fell 0.3% to $4,818.03 an ounce Monday, hitting a one-week low as the dollar and U.S. yields climbed. Oil jumped about 5% after renewed U.S.-Iran tensions, cutting into gold’s safe-haven demand. COMEX gold futures open interest rose to 360,881 contracts. Spot silver dropped 0.8% to $80.18 an ounce, platinum fell 1.2%, and palladium slipped 0.3%.
Boeing Q1 earnings preview: Why BA stock could swing 5% as Wall Street waits for a cash-flow test

Boeing Q1 earnings preview: Why BA stock could swing 5% as Wall Street waits for a cash-flow test

20 April 2026
Boeing shares fell 0.9% to $221.37 Monday ahead of first-quarter results due April 22, with options pricing signaling a 5.31% post-earnings move. Analysts expect another quarterly loss, with revenue near $22 billion and improved jet deliveries. Boeing delivered 143 jets in Q1, ahead of Airbus, but March deliveries slipped due to wiring repairs. Management’s production targets and cash flow outlook remain under scrutiny.
Eli Lilly to Buy Kelonia for Up to $7 Billion in Bet on Next-Gen CAR-T Cancer Therapy

Eli Lilly to Buy Kelonia for Up to $7 Billion in Bet on Next-Gen CAR-T Cancer Therapy

20 April 2026
Eli Lilly will acquire Kelonia Therapeutics for up to $7 billion, including $3.25 billion upfront, expanding into experimental cell therapies for blood cancer. Kelonia’s KLN-1010, in Phase 1 trials for multiple myeloma, uses in-body CAR-T technology. Lilly shares rose 2.5% after the announcement. The deal follows Lilly’s recent acquisitions as it seeks growth beyond obesity drugs.
Boeing Q1 earnings preview: Why BA stock could swing 5% as Wall Street waits for a cash-flow test
Previous Story

Boeing Q1 earnings preview: Why BA stock could swing 5% as Wall Street waits for a cash-flow test

Go toTop